BeOne Medicines Ltd. SG&A Expense 2015-2026 | ONC
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is BeOne Medicines Ltd.'s current sg&a expense?
BeOne Medicines Ltd. (ONC) annual sg&a expense for 2025 was $2.08B, a 13.68% increase from 2024. BeOne Medicines Ltd. sg&a expense for the quarter ending March 31, 2026 was $555.1M.
What was BeOne Medicines Ltd.'s sg&a expense in 2024?
BeOne Medicines Ltd. annual sg&a expense for 2024 was $1.83B, a 21.42% increase from 2023.
What was BeOne Medicines Ltd.'s sg&a expense in 2023?
BeOne Medicines Ltd. annual sg&a expense for 2023 was $1.51B, a 17.94% increase from 2022.
What is BeOne Medicines Ltd.'s 5-year sg&a expense CAGR?
BeOne Medicines Ltd. sg&a expense grew at a compound annual growth rate (CAGR) of 28.24% from FY2020 to FY2025, going from $600.2M to $2.08B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+28.2%
FY2020
$600.2M
→
FY2025
$2.08B
1516171819202122232425
5 years selected
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →